Opiant Pharmaceuticals, Inc. Made Headway
Wed, Jul 07, 2021 at 05:30 PM
Opiant Pharmaceuticals, Inc. (OPNT:NASDAQ) soared at $16.12, a gain of 21.6%. The stock appeared on our News Catalysts scanner on Wed, Jul 07, 2021 at 11:40 AM in the 'BIOTECH' category. From Tue, Jun 22, 2021, the stock recorded 33.33% Up Days and 30.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Opiant Pharmaceuticals, Inc. (OPNT:NASDAQ)
Opiant Pharmaceuticals Inc is a specialty pharmaceutical company. The Company develops opioid pharmacological treatments for substance use, addictive and eating disorders.
Top 10 Gainers:
- NEGG (NEGG:NASDAQ), 148.42%
- Mannatech, Incorporated (MTEX:NASDAQ), 49.69%
- IPW (IPW:NASDAQ), 32.19%
- Peabody Energy Corporation (BTU:NYSE), 24.5%
- Dare Bioscience, Inc. (DARE:NASDAQ), 23.68%
- VVOS (VVOS:NASDAQ), 23.52%
- Exela Technologies, Inc. (XELA:NASDAQ), 22.76%
- OncoSec Medical Incorporated (ONCS:NASDAQ), 21.86%
- Opiant Pharmaceuticals, Inc. (OPNT:NASDAQ), 21.61%
- SMART Global Holdings, Inc. (SGH:NASDAQ), 17.81%